Bellevue Group AG

Q4 2020 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Michael Hutter - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Holdings as of
December 31, 2020
Value $
$8.73B
Num holdings
222
Date filed
2/16/2021, 08:59 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, NBIX, MRNA, VRTX, and ARGX.
Previous filing
Q3 2020 - Nov 16, 2020
Next filing
Q1 2021 - May 12, 2021
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q4 compared to 2020 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Michael Hutter Head Legal & Compliance / CFO Kuesnacht, Switzerland 2/10/2021

Other Included Managers (3):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Zurich 028-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom 028-20408